← 返回

FOXP3:肺癌免疫遗传学架构中的一个参与者

英文原题:FOXP3: A Player of Immunogenetic Architecture in Lung Cancer.

查看英文原题

FOXP3: A Player of Immunogenetic Architecture in Lung Cancer.

PubMed 2024/04/15(内容时间) Genes (Basel) Q2 · IF 3.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

转录因子叉头框蛋白3(FOXP3)被认为是免疫系统中表达于调节性T细胞(Tregs)的重要组分。Tregs是调节免疫稳态和自身耐受的免疫抑制细胞。FOXP3最初被认为是Tregs特异性分子,但近期研究指出FOXP3在多种良性肿瘤和癌中均有表达。绝大多数数据显示FOXP3与不良预后相关,尽管也有少数报道提示该分子具有相反的功能。在此,我们综述了FOXP3在肺癌免疫遗传学架构中作用的最新研究进展,肺癌是癌症相关死亡的首要原因。我们讨论了肿瘤FOXP3表达的预后意义、肿瘤浸润FOXP3淋巴细胞、肿瘤微环境中的肿瘤FOXP3以及FOXP3靶向治疗的潜力。

展开英文摘要原文

The transcription factor forkhead box protein 3 (FOXP3) is considered to be a prominent component of the immune system expressed in regulatory T cells (Tregs). Tregs are immunosuppressive cells that regulate immune homeostasis and self-tolerance.

FOXP3 was originally thought to be a Tregs-specific molecule, but recent studies have pinpointed that FOXP3 is expressed in a diversity of benign tumors and carcinomas. The vast majority of the data have shown that FOXP3 is correlated with an unfavorable prognosis, although there are some reports indicating the opposite function of this molecule.

Here, we review recent progress in understanding the FOXP3 role in the immunogenetic architecture of lung cancer, which is the leading cause of cancer-related death.

We discuss the prognostic significance of tumor FOXP3 expression, tumor-infiltrating FOXP3-lymphocytes, tumor FOXP3 in tumor microenvironments and the potential of FOXP3-targeted therapy.

论文信息

作者
Ziółkowska-Suchanek I、Żurawek M
单位
Institute of Human Genetics, Polish Academy of Sciences, Strzeszyńska 32, 60-479 Poznań, Poland.Poland
文献类型
综述 · 非美国政府资助研究
期刊
Genes2024 Apr 15
原文标识
PubMed 38674427 · DOI 10.3390/genes15040493